3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pain, Postoperative
4
Breast Neoplasms
3
Pain
2
Lung Neoplasms
2
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Hemorrhage
1
Nerve Block
1
Musculoskeletal Diseases
1
Mouth Neoplasms
1
Malignant Neoplasms of Male Genital Organs
1
Hypotension
1
Head and Neck Neoplasms
1
Goiter
1
Chronic Pain
1
Carcinoma, Renal Cell
1
Bowen's Disease
1
Agnosia
1
Acute Upper Gastrointestinal Bleeding
1
Acute Pain
1
Interventions
Colposcopy
13
Imiquimod
12
Conization
11
Papillomavirus Vaccines
8
Cryotherapy
6
Vaccines
5
Papanicolaou Test
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Acetic Acid
4
Watchful Waiting
3
Vaginal Smears
3
Surveys and Questionnaires
3
Biopsy
3
human papillomavirus vaccine, L1 type 16, 18
2
Spectrometry, Fluorescence
2
Proflavine
2
Mass Screening
2
Immunohistochemistry
2
Human Papillomavirus DNA Tests
2
High-Throughput Screening Assays
2
Flow Cytometry
2
Curcumin
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
efineptakin alfa
1
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Dysplasia
×
Epinephrine
×
Clear all
NCT02368054
2016-08-19
HSBAPCB
Helse Fonna
Phase 4
Completed
34 enrolled